General meetings

The shareholders’ influence in the company is exercised at the Annual General Meeting, which is the company’s highest decision-making body. Every shareholder who on the record date of the Annual General Meeting is entered in the share register kept by Euroclear Sweden AB and recorded in a record register or in a record account has the right to participate, in person or through an authorized representative.

AGM 2023

The Annual General Meeting was held at Gradientech’s premises on May 9, 2023. The Annual General Meeting resolved, among other things, on principles for the appointment of the Nomination Committee, new Articles of Association and issue authorization regarding rights issue and directed issue. See documentation from the meeting below.

Proposal to the board

Each shareholder has, regardless of the size of the shareholding, the right to have a specified matter considered at the Annual General Meeting. Shareholders who wish to exercise this right must submit a written request to the company’s board. Such a request shall normally be received by the Board at such a time that the matter can be taken up in the notice convening the Annual General Meeting.

Notice of the AGM

Notice of a general meeting shall be given by advertising in Post- och Inrikes Tidningar and on the company’s website. At the time of summons, information that the summons has been issued shall be announced in Svenska Dagbladet. Notice of the Annual General Meeting and Extraordinary General Meeting where amendments to the Articles of Association are to be considered are issued no earlier than six (6) and no later than four (4) weeks before the Annual General Meeting. Notice of another Extraordinary General Meeting is issued no earlier than six (6) weeks before and no later than two (2) weeks before the Annual General Meeting.

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2023 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book